Tumor microenvironment T-cell recruitment modulation

The phrase "Tumor microenvironment modulation via T-cell recruitment" does not refer to a single molecule or receptor but rather describes a complex biological process involving multiple cellular and molecular components. The tumor microenvironment (TME) can exclude or suppress effector T cells through mechanisms such as altered vasculature, the presence of cancer-associated fibroblasts expressing FAP, production of immunosuppressive cytokines by myeloid-derived suppressor cells, and metabolic changes that induce T-cell exhaustion. Therapeutic strategies aim to overcome these barriers by targeting specific molecules like VEGF receptors with drugs such as axitinib or blocking immune checkpoints like B7-H3. However, this is not a canonical target but an area encompassing several targets and pathways relevant for cancer immunotherapy research[1][2]. Note: This entry is marked as incorrect because it refers to a process rather than a discrete molecular target; structured information should be mapped instead to specific molecules involved in this process such as "Vascular endothelial growth factor receptor 2," "B7-H3," or "Fibroblast activation protein alpha."

Other names

TME T-cell exclusionTumor immune cell recruitmentT-cell trafficking in tumor microenvironment

Inhibition of VEGF signaling to normalize vasculature and enhance T-cell infiltration[1] Blockade of immunosuppressive checkpoints (e.g., B7-H3) to promote anti-tumor immunity[1]